by Stacey Johnson | Oct 16, 2020
The news that Health Canada has approved gene therapy Luxturna to treat blindness couldn’t come at a better time, as October is Blindness Awareness Month. You don’t have to look far to find other high impact research on blindness happening right here in Toronto,...
by Jovana Drinjakovic | Sep 9, 2020
In 2015, Jason Moffat walked into Sheila Singh’s office at McMaster University and gave her a small vial of clear liquid. The vial contained ten milliliters, or two teaspoons, of an injectable antibody, created in Moffat’s lab in Toronto, with a street value of around...
by Sara M. Nolte | May 28, 2020
Cancer immunotherapy is so hot right now. Signals bloggers have covered CAR T cells (here and here), but haven’t given some other exciting immunotherapies their time to shine. I aim to correct that. A normal part of the immune system, checkpoints are a mechanism to...
by David Kent | Apr 30, 2020
Blood stem cells are the fundamental component of regenerative medicine applications involving the blood and immune system. Despite significant efforts and investment, the research community has largely failed to maintain fully functional blood stem cells for...
by Tara Fernandez | Feb 20, 2020
Immunotherapies have been heralded as a revolutionary paradigm shift in how cancer is treated, thanks to the exceptional cancer-killing properties of checkpoint inhibitors and chimeric antigen receptor (CAR) T cells. Today, approved therapies Yescarta™ and Kymriah™,...
Comments